Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PRGO
stocks logo

PRGO

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
1.10B
-3.21%
0.803
-13.64%
1.06B
+1.56%
0.650
+8.33%
1.04B
-1.9%
0.610
+7.02%
Estimates Revision
The market is revising Downward the revenue expectations for Perrigo Company plc (PRGO) for FY2025, with the revenue forecasts being adjusted by -2.93% over the past three months. During the same period, the stock price has changed by -40.44%.
Revenue Estimates for FY2025
Revise Downward
down Image
-2.93%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-7.3%
In Past 3 Month
Stock Price
Go Down
down Image
-40.44%
In Past 3 Month
Wall Street analysts forecast PRGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRGO is 27.50 USD with a low forecast of 23.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast PRGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRGO is 27.50 USD with a low forecast of 23.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 13.490
sliders
Low
23.00
Averages
27.50
High
32.00
Current: 13.490
sliders
Low
23.00
Averages
27.50
High
32.00
Canaccord
Buy
downgrade
$40 -> $20
2025-11-06
Reason
Canaccord
Price Target
$40 -> $20
2025-11-06
downgrade
Buy
Reason
Canaccord lowered the firm's price target on Perrigo to $20 from $40 and keeps a Buy rating on the shares. The firm noted Q3 was a beat but sales were weak in light of OTC trends and lower nutrition sales due to velocities below expectations and lapping a period where infant formula benefited from selling into retailers due to the port strike last year.
JPMorgan
Overweight -> Neutral
downgrade
$32 -> $20
2025-11-06
Reason
JPMorgan
Price Target
$32 -> $20
2025-11-06
downgrade
Overweight -> Neutral
Reason
JPMorgan downgraded Perrigo to Neutral from Overweight with a price target of $20, down from $32, post the Q3 report. The firm sees increased uncertainty for the business in the near term and over the next 12 months. The recovery in Perrigo's infant formula business is slower than expected amid competitive pressure and its over-the-counter market trends are uncertain, the analyst tells investors in a research note. JPMorgan prefers to revisit shares when it gets more clarity on these dynamics.
Jefferies
Keith Devas
Hold
downgrade
$27 -> $23
2025-10-27
Reason
Jefferies
Keith Devas
Price Target
$27 -> $23
2025-10-27
downgrade
Hold
Reason
Jefferies analyst Keith Devas lowered the firm's price target on Perrigo to $23 from $27 and keeps a Hold rating on the shares. Macro headwinds continue to be felt more acutely in consumer health than other pockets of staples, says the analyst, who lowered targets and estimates across the firm's consumer health coverage into Q3 earnings reports from the group.
Canaccord
Susan Anderson
Buy
downgrade
$42 -> $40
2025-08-07
Reason
Canaccord
Susan Anderson
Price Target
$42 -> $40
2025-08-07
downgrade
Buy
Reason
Canaccord analyst Susan Anderson lowered the firm's price target on Perrigo to $40 from $42 and keeps a Buy rating on the shares. The firm updated its model following Q2 results where sales were down but management reiterated both top and bottom-line expectations which are achievable given the company's limited tariff exposure, opportunity to benefit from trade down, new contract wins in PL OTC, and continued strong European business.
Piper Sandler
Korinne Wolfmeyer
Buy
to
Hold
Downgrades
$34 → $27
2025-01-06
Reason
Piper Sandler
Korinne Wolfmeyer
Price Target
$34 → $27
2025-01-06
Downgrades
Buy
to
Hold
Reason
Piper Sandler downgraded Perrigo to Neutral from Overweight with a price target of $27, down from $34.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Perrigo Company PLC (PRGO.N) is 4.63, compared to its 5-year average forward P/E of 12.62. For a more detailed relative valuation and DCF analysis to assess Perrigo Company PLC 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
12.62
Current PE
4.63
Overvalued PE
16.73
Undervalued PE
8.50

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
10.95
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
12.94
Undervalued EV/EBITDA
8.96

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.01
Current PS
0.00
Overvalued PS
1.25
Undervalued PS
0.77
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areBuying! The selling amount has increased 107.21% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areBuying! The selling amount has increased 107.21% over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

PRGO News & Events

Events Timeline

(ET)
2025-11-05
10:00:13
Perrigo Experiences a 20.4% Decline
select
2025-11-05
07:00:49
Perrigo lowers FY25 adjusted EPS forecast to $2.70-$2.80, down from $2.90-$3.10
select
2025-11-05
06:57:33
Perrigo announces Q3 adjusted earnings per share of 80 cents, surpassing consensus estimate of 77 cents.
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.0
01:22 AMGlobenewswire
Stride and Others Face Class Action Lawsuits Amid Significant Investor Losses
  • Stride Lawsuit: Stride, Inc. faces a class action lawsuit for allegedly inflating enrollment figures and cutting teacher staffing from October 22, 2024, to October 28, 2025, which has led to significant investor losses due to undisclosed adverse impacts on the company's operations.
  • Primo Brands Issues: Primo Brands Corporation is being sued for poor merger integration and supply chain disruptions from June 17, 2024, to November 6, 2025, resulting in a severe loss of investor confidence regarding the company's financial outlook.
  • Freeport-McMoran Safety Hazards: Freeport-McMoran Inc. is facing litigation for failing to ensure safety at the Grasberg mine in Indonesia, raising investor concerns about potential regulatory and reputational risks that could negatively impact stock performance.
  • Perrigo Deficiencies: Perrigo Company plc is being sued due to significant manufacturing deficiencies in its acquired infant formula business, undermining investor trust in the company's financial results and potentially affecting future capital expenditures.
[object Object]
Preview
7.0
12-04PRnewswire
Perrigo Faces Class Action for Misleading Statements, Deadline January 16, 2026
  • Allegations of Misleading Statements: Perrigo is accused of issuing materially false or misleading statements from February 27, 2023, to November 4, 2025, leading investors to misunderstand the company's financial health, which negatively impacted stock performance.
  • Need for Capital Expenditures: The lawsuit claims that Perrigo's acquired infant formula business suffered from significant underinvestment in maintenance and operational improvements, necessitating substantial capital and operational expenditures to remediate, potentially straining future finances.
  • Manufacturing Deficiencies: Significant manufacturing deficiencies in the infant formula business's facility led to overstated financial results, further undermining investor confidence in the company's prospects.
  • Call to Action for Investors: Shareholders must register by January 16, 2026, to participate in the class action lawsuit, allowing them to receive updates on the case's progress and the opportunity to become lead plaintiffs, ensuring their rights are protected.
[object Object]
Preview
7.0
12-04Globenewswire
DeFi Technologies Faces Class Action; Shareholders Must Act by January 30
  • Lawsuit Background: DeFi Technologies Inc. (NASDAQ: DEFT) is facing a class action lawsuit for allegedly failing to disclose delays in its DeFi arbitrage strategy, which has led to an inability to meet its fiscal 2025 revenue guidance, with shareholders needing to act by January 30, 2026, to serve as lead plaintiffs.
  • Competitive Pressure: The lawsuit claims that the company underestimated competition from other decentralized finance firms, which negatively impacts its operations and could lead to a sustained decline in future revenues, thereby affecting shareholder value.
  • Skye Bioscience Issues: Skye Bioscience, Inc. (NASDAQ: SKYE) faces a class action lawsuit after failing to disclose that its drug nimacimab was less effective than claimed, resulting in a 60% stock price drop on October 6, 2025, with a lead plaintiff deadline of January 16, 2026.
  • Perrigo Financial Crisis: Perrigo Company plc (NYSE: PRGO) is under scrutiny for not disclosing significant underinvestment in its infant formula business, leading to disappointing Q3 results and a 25.2% stock price drop on November 5, 2025, with shareholders needing to file by the same date.
Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Perrigo Company PLC (PRGO) stock price today?

The current price of PRGO is 13.49 USD — it has decreased -3.37 % in the last trading day.

arrow icon

What is Perrigo Company PLC (PRGO)'s business?

Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.

arrow icon

What is the price predicton of PRGO Stock?

Wall Street analysts forecast PRGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRGO is 27.50 USD with a low forecast of 23.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Perrigo Company PLC (PRGO)'s revenue for the last quarter?

Perrigo Company PLC revenue for the last quarter amounts to 1.04B USD, decreased -4.06 % YoY.

arrow icon

What is Perrigo Company PLC (PRGO)'s earnings per share (EPS) for the last quarter?

Perrigo Company PLC. EPS for the last quarter amounts to 0.05 USD, decreased -133.33 % YoY.

arrow icon

What changes have occurred in the market's expectations for Perrigo Company PLC (PRGO)'s fundamentals?

The market is revising Downward the revenue expectations for Perrigo Company plc (PRGO) for FY2025, with the revenue forecasts being adjusted by -2.93% over the past three months. During the same period, the stock price has changed by -40.44%.
arrow icon

How many employees does Perrigo Company PLC (PRGO). have?

Perrigo Company PLC (PRGO) has 8379 emplpoyees as of December 05 2025.

arrow icon

What is Perrigo Company PLC (PRGO) market cap?

Today PRGO has the market capitalization of 1.86B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free